9 November 2023 - UnitedHealth's pharmacy benefit manager unit said on Thursday it was adding eight insulin products to its reimbursement list that would limit out of pocket spend to $35 or less.

The unit, Optum Rx, will move eight products, including all short- and rapid-acting insulin, to tier one, or preferred status, which offers the lowest price for consumers and is effective 1 January 2024.

Read Reuters article